The CitAD Research Group is seeking applications for new clinical centers to join our existing centers in the conduct of a new clinical trial for the treatment of agitation in dementia funded by the National Institute on Aging.
Overview
Letter from Constantine (Kostas) Lyketsos, MD, MHS, Chairman of the CitAD Research Group
Click here to view the letter from Dr. Lyketsos
Trials
The S-Citalopram for Agitation in Dementia (S-CitAD) Trial is now open for enrollment.
Click here to view the S-CitAD design summary
Scope of work and capitations for clinical centers
Click here to view the scope of work and the study visit capitation schedule
Timeline
- 03 Mar 2017 - first-round applications due
- March 2017 - evaluation by review committee; clinics selected
- Summer 2017 - two-day training meeting in Baltimore, MD
(Coordinators - 1st day; Clinic directors and coordinators - 2nd day) - February 2018 - begin accepting round 2 applications
S-CitAD APPLICATION PROCESS
| 1. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2. | Submit proposed Clinic Director's CV or biosketch (either is OK) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If you need more help, please email us at scitad@citadtrial.org or click the link at the very bottom-right of this page.